HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.

Abstract
In the present study, we have synthesized poly(styrene-co-maleic anhydride), a biocompatible copolymer that was further conjugated with paclitaxel (PTX) via ester linkage and self-assembled to form poly(styrene-co-maleic acid)-paclitaxel (PSMAC-PTX) nanoparticles (NPs). The in vitro release of PTX from PSMAC-PTX NPs showed a higher release at lower pH than at the physiological pH of 7.4, confirming its pH-dependent release. The cell viability of PSMAC-PTX nanoparticles was evaluated using MTT assay. IC50 values of 9.05-18.43 ng/mL of PTX equivalent were observed in various cancer cell lines after 72 h of incubation. Confocal microscopy, Western blotting, and Flow cytometry results further supported that the cellular uptake and apoptosis of cancer cells with PSMAC-PTX NPs. Pharmacokinetic studies revealed that the conjugation of PTX to the PSMAC co-polymer not only increased the plasma and tumor C(max) of PTX but also prolonged its plasma half-life and retention in tumor via enhanced permeability and retention (EPR) effect. Administration of PSMAC-PTX NPs showed significant tumor growth inhibition with improved apoptosis effects in vivo on Ehrlich Ascites Tumor (EAT)-bearing BALB/c syngeneic mice in comparison with Taxol, without showing any cytotoxicity. On the basis of preliminary results, no subacute toxicity was observed in major organs, tissues and hematological system up to a dosage of 60 mg/kg body weight in mice. Therefore, PSMAC-PTX NPs may be considered as an alternative nanodrug delivery system for the delivery of PTX in solid tumors.
AuthorsManu Dalela, T G Shrivastav, Surender Kharbanda, Harpal Singh
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 7 Issue 48 Pg. 26530-48 (Dec 09 2015) ISSN: 1944-8252 [Electronic] United States
PMID26528585 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Biocompatible Materials
  • Maleates
  • Polystyrenes
  • styrene-maleic acid polymer
  • maleic acid
  • Paclitaxel
Topics
  • Administration, Intravenous
  • Animals
  • Antineoplastic Agents, Phytogenic (chemistry, pharmacokinetics, pharmacology, therapeutic use)
  • Area Under Curve
  • Biocompatible Materials (chemistry)
  • Blood Cell Count
  • Body Weight (drug effects)
  • Carcinoma, Ehrlich Tumor (drug therapy, pathology)
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Drug Delivery Systems
  • Drug Liberation
  • Drug Stability
  • Endocytosis (drug effects)
  • Erythrocyte Aggregation (drug effects)
  • Hemolysis (drug effects)
  • Hydrogen-Ion Concentration
  • In Situ Nick-End Labeling
  • Inhibitory Concentration 50
  • Kaplan-Meier Estimate
  • Maleates (chemistry)
  • Maximum Tolerated Dose
  • Mice, Inbred BALB C
  • Nanoparticles (chemistry, ultrastructure)
  • Paclitaxel (chemistry, pharmacokinetics, pharmacology, therapeutic use)
  • Polystyrenes (chemistry)
  • Tissue Distribution (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: